Hospital-based surveillance of invasive pneumococcal disease and pneumonia in South Bangalore, India

Indian Pediatr. 2015 Mar 8;52(3):205-11. doi: 10.1007/s13312-015-0607-0.

Abstract

Objective: To estimate the incidence of invasive pneumococcal disease and pneumonia, distribution of pneumococcal serotypes, and antibiotic susceptibility in children aged 28 days to <60 months.

Design: Hospital-based surveillance.

Setting: South Bangalore, India.

Participants: 9950 children aged 28 days to <60 months with clinical suspicion of invasive pneumococcal disease or pneumonia.

Results: The estimated at-risk population included 224,966 children <5 years of age. Forty cases of invasive pneumococcal disease were identified. Estimated invasive pneumococcal disease incidence was 17.8/100,000 with incidence being highest among children aged 6 months to <12 months (49.9/100,000). Clinical pneumonia syndrome was the most frequent diagnosis (12.5/100,000). Pneumococcal serotypes included: 6A (n=6, 16.7%); 14 (n=5, 13.9%); 5 (n=4, 11.1%); 6B (n=4, 11.1%); 1, 18C, and 19A (n=3 each, 8.3%); 9V (n=2, 5.6%); and 3, 4, 10C, 18A, 18F, and 19F (n=1 each, 2.8%). Serotypes 6A, 14, 6B, 1, 18C, 19A, 9V, 4, 10C, and 18A showed antibiotic resistance. Clinical pneumonia incidence was 2109/100,000, with incidence being highest among children aged 28 days to <6 months (5033/100,000). Chest radiograph-confirmed pneumonia incidence was 1114/100,000, with incidence being highest among children aged 28 days to <6 months (2413/100,000).

Conclusions: Invasive pneumococcal disease and pneumonia were found to be common causes of morbidity in young children living in South Bangalore, India.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Child
  • Child, Preschool
  • Female
  • Hospitals
  • Humans
  • India / epidemiology
  • Infant
  • Male
  • Microbial Sensitivity Tests
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / microbiology*
  • Public Health Surveillance
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / isolation & purification*

Substances

  • Anti-Bacterial Agents